Lichen Planopilaris Responsive to a Novel Phytoactive Botanical Treatment: A Case Series

June 2022 in “ Dermatology and therapy ”

Sanusi Umar, Petrina Kan, Marissa J. Carter, Paul Shitabata, Myroslava Novosilska

lichen planopilaris botanical formulation Dr. UGro Gashee hair growth scalp itch tenderness irritation topical treatment oral treatment LPP UGro Gashee

TLDR A new botanical treatment improved hair growth and symptoms in lichen planopilaris patients.

A case series of four patients with biopsy-proven lichen planopilaris (LPP) treated with a novel botanical formulation (Dr. UGro Gashee) showed promising results. The patients, who had previously failed conventional treatments, experienced significant improvement in hair growth, cessation of disease progression, and resolution of symptoms such as scalp itch, tenderness, and irritation. The treatment, administered topically or in combination with its oral form, was used for 6 weeks to 9.5 months and resulted in high patient satisfaction with no adverse effects. This study suggests that the botanical formulation could be a safer and more effective alternative for LPP, warranting further evaluation in larger controlled trials.

View this study on link.springer.com →

Discuss this study in the Community →

Research cited in this study

10 / 10 results

research A Multimodal Hair-Loss Treatment Strategy Using a New Topical Phytoactive Formulation: A Report of Five Cases

2 citations, February 2021 in “Case reports in dermatological medicine”

The new topical botanical formulation significantly regrew hair in all five patients without side effects.

Lichen Planopilaris and Low-Level Light Therapy: Four Case Reports and Review of the Literature About Low-Level Light Therapy and Lichenoid Dermatosis

research Lichen Planopilaris and Low-Level Light Therapy: Four Case Reports and Review of the Literature About Low-Level Light Therapy and Lichenoid Dermatosis

11 citations, February 2020 in “Dermatology and therapy”

Low-Level Light Therapy significantly reduced inflammation and promoted hair regrowth in patients with Lichen planopilaris.

research Frontal Fibrosing Alopecia: An Update on the Hypothesis of Pathogenesis and Treatment

38 citations, January 2019 in “International Journal of Women's Dermatology”

The document concluded that more research is needed to find the best treatment for Frontal fibrosing alopecia.

research Tofacitinib for the Treatment of Lichen Planopilaris: A Case Series

79 citations, September 2018 in “Dermatologic therapy”

Oral tofacitinib can significantly improve recalcitrant lichen planopilaris.

Cicatricial Alopecia Research Foundation Meeting, May 2016: Progress Towards the Diagnosis, Treatment, and Cure of Primary Cicatricial Alopecias

research Cicatricial Alopecia Research Foundation Meeting, May 2016: Progress Towards the Diagnosis, Treatment, and Cure of Primary Cicatricial Alopecias

22 citations, January 2018 in “Experimental Dermatology”

The meeting focused on understanding, diagnosing, and finding treatments for irreversible hair loss diseases.

research Novel Treatment Using Low-Dose Naltrexone for Lichen Planopilaris

39 citations, November 2017 in “PubMed”

Low-dose naltrexone helps reduce symptoms and slow down lichen planopilaris without side effects.

research Platelet-Rich Plasma as a Novel Treatment for Lichen Planopillaris

29 citations, March 2016 in “Dermatologic therapy”

Platelet-rich plasma may successfully treat lichen planopillaris, as shown by one patient's symptom regression.

research Lichen planopilaris is characterized by immune privilege collapse of the hair follicle's epithelial stem cell niche

220 citations, June 2013 in “The Journal of Pathology”

research Cicatricial (Scarring) Alopecias: Comprehensive Review and Management

44 citations, April 2012 in “American Journal of Clinical Dermatology”

Scarring alopecias are complex hair loss disorders that require early treatment to prevent permanent hair loss.

research Lichen Planopilaris Treated With a Peroxisome Proliferator-Activated Receptor Gamma Agonist

105 citations, December 2009 in “Archives of dermatology”

A specific drug can help treat Lichen Planopilaris, a condition causing permanent hair loss.

Related Community Posts Join

6 / 37 results

community The Worst Hair Loss Condition You (MAY) have: LPP

in Research/Science 43 upvotes 2 months ago

Lichen Planopilaris (LPP) is an autoimmune condition causing permanent hair loss and fibrosis, often misdiagnosed. Treatments include pioglitazone, topical corticosteroids, anti-inflammatory medication, and Jak inhibitors.

community scarring alopecia awareness in this community

in Chat 33 upvotes 2 years ago

Lichen Planopilaris (LPP), a form of permanent hair loss, which can be mistaken for seborrheic dermatitis and is characterized by scalp itching, burning, redness, and dandruff. Treatment options discussed include steroidal creams, finasteride, minoxidil, and RU58841.

community Making the jump to hair systems

in Hair Systems 27 upvotes 3 years ago

19-year-old with Lichen Planopilaris tried various treatments unsuccessfully. Now considering hair systems, seeking experiences and opinions.

community Anger and frustration as I finally learn my diagnosis.

in Female 6 upvotes 1 year ago

A young female diagnosed with Lichen planopilaris (LPP) experienced years of misdiagnosis and ineffective treatments, including a hair transplant and other procedures. She is considering litigation due to the misdiagnosis and has learned that LPP is chronic, hair loss can be stopped with ongoing medication, but lost hair cannot regrow.

community Diffuse hair loss and scalp biopsies

in Research 692 upvotes 3 months ago

Scalp biopsies are crucial for diagnosing hair loss conditions like Diffuse Unpatterned Alopecia (DUPA) and retrograde hair loss, as treatments like finasteride and dutasteride may not be effective if other conditions are present. Combining PPAR-GAMMA agonists with retinoids could improve treatments for conditions like Lichen Planopilaris.

community Clascoterone (Winlevi) Update for Canada

in Treatment 16 upvotes 2 years ago

Clascoterone cream was submitted for review to Health Canada in August 2022, with hopes of approval within 3-6 months. It may potentially enhance finasteride's effects for hair loss treatment.